Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANSS
5351
PUT
DELISTED
Ansys
ANSS
| $112K | ﹤0.01% |
600
-3,700
| -86% | -$662K |
|
5352
CALL
Gentex
GNTX
$5.04B
| $112K | ﹤0.01% |
5,200
+2,500
| +93% | +$57.8K |
|
|
CMRX
5353
DELISTED
Chimerix, Inc.
CMRX
| $112K | ﹤0.01% |
29,104
+25,260
| +657% | +$108K |
|
|
FNJN
5354
DELISTED
Finjan Holdings, Inc.
FNJN
| $112K | ﹤0.01% |
+26,000
| New | +$109K |
|
|
EMES
5355
DELISTED
Emerge Energy Services LP
EMES
| $112K | ﹤0.01% |
28,008
-137,445
| -83% | -$815K |
|
5356
AXT Inc
AXTI
$4.83B
| $111K | ﹤0.01% |
15,532
+12,078
| +350% | +$91.9K |
|
5357
PUT
Cooper Companies
COO
$15B
| $111K | ﹤0.01% |
1,600
-3,200
| -67% | -$206K |
|
|
FARM
5358
DELISTED
Farmer Brothers
FARM
| $111K | ﹤0.01% |
4,196
+3,220
| +330% | +$92.3K |
|
5359
RCI Hospitality Holdings
RICK
$210M
| $111K | ﹤0.01% |
3,717
+2,662
| +252% | +$84.8K |
|
|
EMCI
5360
DELISTED
EMC INS Group Inc
EMCI
| $111K | ﹤0.01% |
4,447
+3,673
| +475% | +$96.8K |
|
5361
BayCom
BCML
$341M
| $110K | ﹤0.01% |
4,109
+3,358
| +447% | +$85.6K |
|
|
BEDU
5362
DELISTED
Bright Scholar Education Holdings
BEDU
| $110K | ﹤0.01% |
+2,226
| New | +$122K |
|
|
CASI
5363
DELISTED
CASI Pharmaceuticals
CASI
| $110K | ﹤0.01% |
2,360
+1,983
| +526% | +$138K |
|
5364
Ceco Environmental
CECO
$4.32B
| $110K | ﹤0.01% |
13,948
+11,281
| +423% | +$85.9K |
|
5365
Graham Corp
GHM
$1.28B
| $110K | ﹤0.01% |
3,913
+3,213
| +459% | +$86.8K |
|
5366
Hingham Institution for Saving
HIFS
$684M
| $110K | ﹤0.01% |
503
+405
| +413% | +$88.8K |
|
5367
SmartFinancial
SMBK
$888M
| $110K | ﹤0.01% |
4,678
+3,846
| +462% | +$95.7K |
|
|
LN
5368
CALL
DELISTED
LINE Corporation
LN
| $110K | ﹤0.01% |
2,600
+200
| +8% | +$8.68K |
|
5369
Acacia Research
ACTG
$451M
| $109K | ﹤0.01% |
33,957
-3,871
| -10% | -$14.4K |
|
5370
Consumer Portfolio Services
CPSS
$198M
| $109K | ﹤0.01% |
29,374
+19,417
| +195% | +$71.5K |
|
|
FINV
5371
FinVolution Group
FINV
$1.05B
| $109K | ﹤0.01% |
20,274
-10,326
| -34% | -$53.7K |
|
|
HONE
5372
DELISTED
HarborOne Bancorp
HONE
| $109K | ﹤0.01% |
10,219
+8,311
| +436% | +$88.4K |
|
5373
Southern First Bancshares
SFST
$603M
| $109K | ﹤0.01% |
2,777
+2,274
| +452% | +$98K |
|
5374
PUT
Direxion Daily Small Cap Bear 3x ETF
TZA
$203M
| $109K | ﹤0.01% |
33
-15
| -31% | -$50.7K |
|
|
PVLA
5375
Palvella Therapeutics
PVLA
$2.22B
| $109K | ﹤0.01% |
243
+195
| +406% | +$84.7K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.